The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines.EBI
Glaxosmithkline
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.EBI
Astex Pharmaceuticals
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.EBI
Glaxosmithkline
Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.EBI
Nippon Boehringer Ingelheim
The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery.EBI
Bristol-Myers Squibb
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.EBI
Kanazawa University
Interaction of silymarin flavonolignans with organic anion-transporting polypeptides.EBI
University Of North Carolina At Chapel Hill
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.EBI
Glaxosmithkline
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.EBI
Universit£Tsmedizin G£Ttingen
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition.EBI
Novartis Institutes For Biomedical Research
Structure-based identification of OATP1B1/3 inhibitors.EBI
Ku Leuven
Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.EBI
Pfizer
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.EBI
Kitasato University
Lead optimisation of pyrazoles as novel FPR1 antagonists.EBI
Astrazeneca
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.EBI
Uppsala University
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.EBI
University Hospital
Discovery of AZD2716: A Novel Secreted Phospholipase AEBI
Astrazeneca
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease.EBI
TBA
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy.EBI
Gsk Pharmaceuticals R&D
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.EBI
Glaxosmithkline
Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver.EBI
University Of Zurich
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.EBI
Deutsches Krebsforschungszentrum
Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.EBI
Kanazawa University
Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins.EBI
Deutsches Krebsforschungszentrum
Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles.EBI
Chinese Academy Of Sciences
Synthesis of 4-[2-(3,4-dimethoxybenzyl)cyclopentyl]-1,2-dimethoxybenzene Derivatives and Evaluations of Their Carbonic Anhydrase Isoenzymes Inhibitory Effects.BDB
Atat£Rk University